Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression | |
Guo, Lanfang[1]; Gu, Jianmei[2]; Hou, Sinan[3]; Liu, Dabiao[4]; Zhou, Mengjie[5]; Hua, Tengjiang[6]; Zhang, Jinye[7]; Ge, Zhijun[8]; Xu, Jing[9] | |
刊名 | ONCOTARGETS AND THERAPY |
2019 | |
卷号 | 12页码:135-146 |
关键词 | DANCR NSCLC progression biomarker |
ISSN号 | 1178-6930 |
DOI | http://dx.doi.org/10.2147/OTT.S186607 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000454390800001 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5325073 |
专题 | 江苏大学 |
作者单位 | 1.[1]Fourth Peoples Hosp Zhenjiang, Dept Clin Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China. 2.[2]Nantong Tumor Hosp, Dept Clin Lab Med, Nantong 226361, Jiangsu, Peoples R China. 3.[3]Lianyungang Tradit Chinese Med Hosp, Dept Clin Lab Med, Lianyungang 222002, Jiangsu, Peoples R China. 4.[4]Fourth Peoples Hosp Zhenjiang, Dept Clin Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China. 5.[5]Fourth Peoples Hosp Zhenjiang, Dept Clin Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China. 6.[6]Fourth Peoples Hosp Zhenjiang, Dept Clin Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China. 7.[7]Nantong Tumor Hosp, Dept Clin Lab Med, Nantong 226361, Jiangsu, Peoples R China. 8.[8]Jiangsu Univ, Dept Crit Care Med, Affiliated Yixing Hosp, 75 Tongzhenguan Rd, Yixing 214200, Jiangsu, Peoples R China. 9.[9]Jiangsu Univ, Dept Clin Lab Med, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212013, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Guo, Lanfang[1],Gu, Jianmei[2],Hou, Sinan[3],et al. Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression[J]. ONCOTARGETS AND THERAPY,2019,12:135-146. |
APA | Guo, Lanfang[1].,Gu, Jianmei[2].,Hou, Sinan[3].,Liu, Dabiao[4].,Zhou, Mengjie[5].,...&Xu, Jing[9].(2019).Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression.ONCOTARGETS AND THERAPY,12,135-146. |
MLA | Guo, Lanfang[1],et al."Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression".ONCOTARGETS AND THERAPY 12(2019):135-146. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论